JP MORGAN 2015: Roche in dealmaking mode for antibiotics, diagnostics
This article was originally published in Scrip
Executive Summary
Roche told Scrip on 12 January during the 33rd Annual JP Morgan Healthcare Conference in San Francisco that the company is actively looking to do deals in oncology, neurology and infectious diseases and by the end of the day unveiled a new licensing deal for a Phase I antibiotic.